Related references
Note: Only part of the references are listed.Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells
Su Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer
Hiroshi Hongo et al.
CANCER SCIENCE (2018)
Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters
Hideo Otsuki et al.
PROSTATE (2017)
Aurora B expression modulates paclitaxel response in non-small cell lung cancer
Ahmed S. K. Al-Khafaji et al.
BRITISH JOURNAL OF CANCER (2017)
Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
P. Khongkow et al.
ONCOGENE (2016)
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice
Pouria Jandaghi et al.
GASTROENTEROLOGY (2016)
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar et al.
NATURE MEDICINE (2016)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Kif20a inhibition reduces migration and invasion of pancreatic cancer cells
Daniela Stangel et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Knockdown of Aurora-B alters osteosarcoma cell malignant phenotype via decreasing phosphorylation of VCP and NF-κB signaling
Jian Ying He et al.
TUMOR BIOLOGY (2015)
Molecular mechanisms underlying variations in lung function: a systems genetics analysis
Ma'en Obeidat et al.
LANCET RESPIRATORY MEDICINE (2015)
Dietary Tomato and Lycopene Impact Androgen Signaling- and Carcinogenesis-Related Gene Expression during Early TRAMP Prostate Carcinogenesis
Lei Wan et al.
CANCER PREVENTION RESEARCH (2014)
Discovery of the neuroprotective effects of alvespimycin by computational prioritization of potential anti-parkinson agents
Li Gao et al.
FEBS JOURNAL (2014)
3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer
Yuqiao Sheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
KIF3a Promotes Proliferation and Invasion via Wnt Signaling in Advanced Prostate Cancer
Zun Liu et al.
MOLECULAR CANCER RESEARCH (2014)
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
Mannan Nouri et al.
FRONTIERS IN ONCOLOGY (2014)
Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming
Takeo Kosaka et al.
CANCER SCIENCE (2013)
Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor
Yusuke Tomita et al.
CLINICAL CANCER RESEARCH (2013)
Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance
Thea Eline Hetland et al.
HUMAN PATHOLOGY (2013)
Gene Expression of Aurora Kinases in Prostate Cancer and Nodular Hyperplasia Tissues
Emmanuel Nna et al.
MEDICAL PRINCIPLES AND PRACTICE (2013)
Mitosis Phase Enrichment with Identification of Mitotic Centromere-Associated Kinesin As a Therapeutic Target in Castration-Resistant Prostate Cancer
Kanishka Sircar et al.
PLOS ONE (2012)
mRNA Expression Signatures of Human Skeletal Muscle Atrophy Identify a Natural Compound that Increases Muscle Mass
Steven D. Kunkel et al.
CELL METABOLISM (2011)
Network medicine: a network-based approach to human disease
Albert-Laszlo Barabasi et al.
NATURE REVIEWS GENETICS (2011)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Discovery of drug mode of action and drug repositioning from transcriptional responses
Francesco Iorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds
Katleen De Preter et al.
CLINICAL CANCER RESEARCH (2009)
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis
Robert W. Wilkinson et al.
CLINICAL CANCER RESEARCH (2007)
Innovation - The Connectivity Map: a new tool for biomedical research
Justin Lamb
NATURE REVIEWS CANCER (2007)
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
Guo Wei et al.
CANCER CELL (2006)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation
P Chieffi et al.
PROSTATE (2006)
Relocation of Aurora B from centromeres to the central spindle at the metaphase to anaphase transition requires MKIp2
U Gruneberg et al.
JOURNAL OF CELL BIOLOGY (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis
R Neef et al.
JOURNAL OF CELL BIOLOGY (2003)
Share Paper
